Back to Search
Start Over
IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody.
- Source :
-
Transplantation [Transplantation] 2016 Sep; Vol. 100 (9), pp. 1853-61. - Publication Year :
- 2016
-
Abstract
- Background: The maintenance or expansion of regulatory T (Treg) cells has a fundamental role in the achievement of immunological tolerance after transplantation. Here we aimed to determine mechanisms of human Treg cell depletion and reconstitution after anti-CD25 monoclonal antibody (mAb) treatment.<br />Methods: Seventeen patients with type 1 diabetes who received pancreatic islet transplantation and anti-CD25 mAb as induction therapy were studied.<br />Results: We observed an almost complete depletion of Treg cells after injection of anti-CD25 mAb. The kinetic of Treg cell depletion did not parallel the disappearance of CD25+ T cells as CD25 is also rapidly downregulated and internalized. Regulatory T cell reconstitution is completed within 6 months posttransplantation and appeared to be driven by IL-7-mediated homeostatic T cell proliferation. Anti-CD25 mAb treatment sensitizes Treg cell to the biological effect of IL-7, possibly rendering more common γc-chain available to interact with CD127. Homeostatic Treg cell proliferation is resistant to the inhibitory effect of rapamycin and FK506 but can be blocked by the presence of mycophenolate mofetil.<br />Conclusions: Our data suggest that a compensatory mechanism of IL-7-mediated homeostatic proliferation can restore the inhibitory network of Treg cell after anti-CD25 induction therapy in islet allotransplantation.
- Subjects :
- Adult
Allografts
Antibodies, Monoclonal adverse effects
Basiliximab
Cells, Cultured
Diabetes Mellitus, Type 1 diagnosis
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Forkhead Transcription Factors blood
Humans
Immunologic Memory drug effects
Immunosuppressive Agents adverse effects
Interleukin Receptor Common gamma Subunit immunology
Interleukin-2 Receptor alpha Subunit blood
Interleukin-7 Receptor alpha Subunit immunology
Male
Middle Aged
Mycophenolic Acid therapeutic use
Recombinant Fusion Proteins adverse effects
Signal Transduction drug effects
Sirolimus therapeutic use
T-Lymphocytes, Regulatory immunology
T-Lymphocytes, Regulatory metabolism
Tacrolimus therapeutic use
Time Factors
Treatment Outcome
Antibodies, Monoclonal therapeutic use
Cell Proliferation drug effects
Diabetes Mellitus, Type 1 surgery
Forkhead Transcription Factors immunology
Immunosuppressive Agents therapeutic use
Interleukin-2 Receptor alpha Subunit immunology
Interleukin-7 pharmacology
Islets of Langerhans Transplantation adverse effects
Lymphocyte Depletion methods
Recombinant Fusion Proteins therapeutic use
T-Lymphocytes, Regulatory drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1534-6080
- Volume :
- 100
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Transplantation
- Publication Type :
- Academic Journal
- Accession number :
- 27306531
- Full Text :
- https://doi.org/10.1097/TP.0000000000001276